The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic and renal toxicities have been reported previously with the administration of phosphorothioate antisense oligonucleotides, as have complement activation and prolongation of PTT due to interaction with complement and coagulation factor [16].”
From Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors (2014) · cites this paper as [16]
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., & Krieg, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,477
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., & Bennett, C. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55250-9 · Cited by 463
Krieg, A. M., Love-Homan, L., Yi, A.-K., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 379
Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.
Brown, D. A., Kang, S. H., Gryaznov, S. M., DeDionisio, L., Heidenreich, O., Sullivan, S., Xu, X., & Nerenberg, M. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47090-1 · Cited by 336
Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y. X., Bayewitch, L. A., Cohen, A. M., Herrera, C. J., Hu, S. S., & Kramer, T. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4051 · Cited by 320
Research works printed but not linked: 27
- Cossum, 1994, J. Pharmacol. Exp. Ther., 269, 89
- Henry, 1996, Toxicologist, 30, 112
- Leeds, 1996, Pharm. Res., 13, S
- Cossum, 1993, J. Pharmacol. Exp. Ther., 267, 1181
- Glover, 1997, J. Pharmacol. Exp. Ther., 282, 1173
- Crooke, 1996, J. Pharmacol. Exp. Ther., 277, 923
- Iversen, 1991, Anti-Cancer Drug Des., 6, 531
- Saijo, 1994, Oncol. Res., 6, 243
- Sands, 1994, Mol. Pharmacol., 45, 932
- Leeds, 1996, Fundam. Appl. Toxicol., 30, 40
- Rifai, 1996, Am. J. Pathol., 149, 717
- A.A. Levin, R.S. Geary, J.M. Leeds, D.K. Monteith, R. Yu, M.V. Templin, S.P. Henry, in: J.A. Thomas (Ed.), Biotechnology and Safety Assessment, vol. 1, 2nd edn., Taylor and Francis, Philadelphia, PA, 1998, pp. 151–176.
- Geary, 1997, Drug Metab. Dispos., 25, 1272
- Butler, 1997, Lab. Invest., 77, 379
- L.L. Cummins, J.M. Leeds, M. Greig, R.J. Griffey, M.J. Graham, R. Crooke, H.J. Gaus, in: IRT: Nucleosides and Nucleotides, vol. 1, La Jolla, CA, 1996, p. 72.
- Nicklin, 1997, Proc. Natl. Acad. Sci. USA, 16, 1145
- Monteith, 1997, Anti-Cancer Drug Des., 12, 421
- A. Krieg, in: S.T. Crooke (Ed.), Antisense Research and Applications, vol. 131, 1st edn., Springer-Verlag, Berlin, 1998, pp. 217–262. · DOI
- Bennett, 1997, J. Pharmacol. Exp. Ther., 280, 988
- Bacon, 1991, Oncogene Res., 6, 13
- Wallace, 1996, J. Pharmacol. Exp. Ther., 278, 1306
- Henry, 1997, J. Pharmacol. Exp. Ther., 281, 810
- Cornish, 1993, Pharmacol. Commun., 3, 239
- Henry, 1994, Pharm. Res., 11, S
- Henry, 1997, Anti-Cancer Drug Des., 12, 395
- Horner, 1997, Fundam. Appl. Toxicol., 36, 147
- Manza, 1997, Fundam. Appl. Toxicol., 36, 147
Cited by
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,726
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Metadata
- Authors
- Levin, A. A.
- Corresponding author
- Levin, Arthur A
- ORCID
- Levin, Arthur A
- Venue
- Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 1489
- Issue
- 1
- Pages
- 69-84
- ISSN
- 0167-4781 (ISSN-L)
- OpenAlex
- W2020713872
- Cited by
- 438
- References
- 82
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 13 · 2018: 16 · 2017: 10 · 2016: 19 · 2015: 18 · 2014: 16 · 2013: 18 · 2012: 32
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- phosphorothioate antisense oligonucleotides, pharmacokinetics, toxicology, antisense therapy
- MeSH terms
- Animals, Haplorhini, Blood Coagulation, Cells, Complement Activation, Drug Administration Routes, Humans, Mutagenicity Tests, Nucleic Acid Hybridization, Organ Specificity, Protein Binding, RNA, Thionucleotides, Tissue Distribution, Oligonucleotides, Antisense, Drug Delivery Systems, Complement Factor H, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. https://app.cochat.ai/papers/10.1016/s0167-4781(99)00140-2
- The paper
- Levin, A. A. (1999). A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. https://doi.org/10.1016/s0167-4781(99)00140-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.